Pepscan Holding NV (Pepscan Therapeutics BV & Pepscan Presto BV)

Pepscan Systems has proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives.

We have a strong record of accomplishment and are active in the fields of:

* Peptide arrays for lead discovery and T-cell epitope mapping * Mapping of linear, conformational and discontinuous antibody epitopes * Substrate profiling of proteases, kinases and phosphatases * Identification and optimization of leads for therapeutics and synthetic vaccines.

Pepscan Services offers its proprietary products and services on the basis of fee-for-service and in risk-sharing collaborations.

Pepscan Therapeutics applies these technologies in a strong internal pipeline of novel immunotherapeutics in oncology.